Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
70.21
-1.55 (-2.16%)
At close: Aug 19, 2025, 3:59 PM
70.19
-0.03%
After-hours: Aug 19, 2025, 04:32 PM EDT
Corcept Therapeutics Revenue
Corcept Therapeutics reported an annual revenue of $675.04M, reflecting a 39.94% growth. For the quarter ending June 30, 2025, Corcept Therapeutics generated $194.43M in revenue.
Revenue (ttm)
675.04M
Revenue Growth
39.94%
Price / Sales Ratio
7.71
Revenue / Employee
1.35M
Employees
500
Market Cap
7.4B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 675.04M | +39.94% |
| Dec 31, 2023 | 482.38M | +20.04% |
| Dec 31, 2022 | 401.86M | +9.80% |
| Dec 31, 2021 | 365.98M | +3.42% |
| Dec 31, 2020 | 353.87M | +15.46% |
| Dec 31, 2019 | 306.49M | +21.99% |
| Dec 31, 2018 | 251.25M | +57.82% |
| Dec 31, 2017 | 159.2M | +95.77% |
| Dec 31, 2016 | 81.32M | +61.72% |
| Dec 31, 2015 | 50.29M | +89.39% |
| Dec 31, 2014 | 26.55M | +156.36% |
| Dec 31, 2013 | 10.36M | +213.18% |
| Dec 31, 2012 | 3.31M | +Infinity% |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | -100.00% |
| Dec 31, 2009 | 29K | -86.12% |
| Dec 31, 2008 | 209K | -56.64% |
| Dec 31, 2007 | 482K | +63.95% |
| Dec 31, 2006 | 294K | +Infinity% |
| Dec 31, 2005 | 0 | n/a |
| Dec 31, 2004 | 0 | n/a |
| Dec 31, 2003 | 0 | n/a |
| Dec 31, 2002 | 0 | n/a |
| Dec 31, 2001 | 0 | n/a |